5 NICEの5年間

Same author

The UK's Life Sciences Strategy: opportunities for clinical pharmacology.

British journal of clinical pharmacology·2018

Same author

Cost, Effectiveness, and Value: How to Judge?

JAMA·2016

Same author

Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.

BMJ open·2016

Same author

The Prevalence of Huntington's Disease.

Neuroepidemiology·2016

Same author

National Institute for Clinical Excellence: NICE works.

Journal of the Royal Society of Medicine·2015

Same author

Author's reply to Poole, Conway, Bewley, Sundar, and Chalmers and Firkins.

BMJ (Clinical research ed.)·2014

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

5 NICEの5年間

関連する概念動画

The UK's Life Sciences Strategy: opportunities for clinical pharmacology.

Cost, Effectiveness, and Value: How to Judge?

Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.

The Prevalence of Huntington's Disease.

National Institute for Clinical Excellence: NICE works.

Author's reply to Poole, Conway, Bewley, Sundar, and Chalmers and Firkins.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

5 NICEの5年間

関連する概念動画

関連記事

The UK's Life Sciences Strategy: opportunities for clinical pharmacology.

Cost, Effectiveness, and Value: How to Judge?

Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.

The Prevalence of Huntington's Disease.

National Institute for Clinical Excellence: NICE works.

Author's reply to Poole, Conway, Bewley, Sundar, and Chalmers and Firkins.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.